Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for
11:02am, Wednesday, 29'th Jul 2026
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allspring Global Investments Holdings LLC Has $100.21 Million Position in Qiagen N.V. $QGEN
03:09am, Saturday, 18'th Jul 2026
Allspring Global Investments Holdings LLC lessened its holdings in shares of Qiagen N.V. (NYSE: QGEN) by 21.6% during the undefined quarter, according to its most recent disclosure with the SEC. The f
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
04:05pm, Wednesday, 15'th Jul 2026
GERMANTOWN, Md., & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today highlighted its portfolio of molecular testing solutions support
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
08:48am, Wednesday, 15'th Jul 2026
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026. Press release date / time: Wednes
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
04:05pm, Tuesday, 14'th Jul 2026
VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the CE-IVDR-certified QIAstat-Dx BCID GN
Qiagen: New Launches Signal A Turnaround
05:08am, Sunday, 12'th Jul 2026
Qiagen N.V. is rated a Buy, supported by new product launches and automation initiatives poised to drive revenue growth. QGEN's QIAspirant Connect and partnerships like Inpeco/Diasorin and NVIDIA AI c
Qiagen draws early takeover interest from EQT, Advent & KKR, Bloomberg News reports
11:04am, Thursday, 09'th Jul 2026
Qiagen is drawing early takeover interest from buyout firms, including EQT AB , Advent and KKR , Bloomberg News said on Thursday, citing people familiar with the
Qiagen N.V. (QGEN) Shareholder/Analyst Call Transcript
08:42am, Wednesday, 24'th Jun 2026
Qiagen N.V. (QGEN) Shareholder/Analyst Call Transcript
Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcript
04:12pm, Monday, 15'th Jun 2026
Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcript
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use
12:21pm, Monday, 15'th Jun 2026
QGEN's QIAcuity expansion adds gene expression assays, multiplexing, automation and analysis tools to drive dPCR adoption.
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
01:30am, Monday, 15'th Jun 2026
VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to its QIAcuity digital PCR (dPCR) ecosys
A Look at Qiagen NV (QGEN) After 4.2% Gain -- GF Value $52.66 vs Price $37.75
07:52pm, Tuesday, 09'th Jun 2026
On June 09, 2026, Qiagen NV (QGEN) shares rose 4.2% today, bringing the current price to $37.75. The stock has experienced a 52-week range, hitting a high of $5
Qiagen (QGEN) Up 12.1% Since Last Earnings Report: Can It Continue?
12:35pm, Friday, 05'th Jun 2026
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
10:00am, Thursday, 04'th Jun 2026
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. ("Qiagen" or the "Company") (NYSE: QGEN).
Qiagen N.V. (QGEN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
03:12pm, Wednesday, 03'rd Jun 2026
Qiagen N.V. (QGEN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
